Reaction Details |
 | Report a problem with these data |
Target | HIV-1 Protease Mutant M3 (L10I, L63P, A71V, G73S, I84V, L90M) |
---|
Ligand | BDBM13934 |
---|
Substrate/Competitor | HIV-1 Protease Substrate |
---|
Meas. Tech. | Enzyme Inhibition Assay |
---|
Ki | 0.49±n/a nM |
---|
Citation | Reddy, GS; Ali, A; Nalam, MN; Anjum, SG; Cao, H; Nathans, RS; Schiffer, CA; Rana, TM Design and Synthesis of HIV-1 Protease Inhibitors Incorporating Oxazolidinones as P2/P2' Ligands in Pseudosymmetric Dipeptide Isosteres. J Med Chem50:4316-28 (2007) [PubMed] Article |
---|
More Info.: | Get all data from this article, Solution Info, Assay Method |
---|
|
HIV-1 Protease Mutant M3 (L10I, L63P, A71V, G73S, I84V, L90M) |
---|
Name: | HIV-1 Protease Mutant M3 (L10I, L63P, A71V, G73S, I84V, L90M) |
Synonyms: | n/a |
Type: | Protein Complex |
Mol. Mass.: | n/a |
Description: | n/a |
Components: | This complex has 2 components. |
Component 1 |
Name: | HIV-1 Protease Mutant M3 (L10I, L63P, A71V, G73S, I84V, L90M) chain A |
Synonyms: | HIV-1 Protease Mutant M3 (L10I, L63P, A71V, G73S, I84V, L90M) chain B |
Type: | Enzyme Subunit |
Mol. Mass.: | 10869.31 |
Organism: | Human immunodeficiency virus type 1 |
Description: | O38732 mutant |
Residue: | 99 |
Sequence: | PQITLWKRPIVTIRIGGQLKEALLDTGADDTVLEEMNLPGKWKPKMIGGIGGFIKVRQYD
QIPIEICGHKVISTVLVGPTPVNVIGRNLMTQIGCTLNF
|
|
|
Component 2 |
Name: | HIV-1 Protease Mutant M3 (L10I, L63P, A71V, G73S, I84V, L90M) chain A |
Synonyms: | HIV-1 Protease Mutant M3 (L10I, L63P, A71V, G73S, I84V, L90M) chain B |
Type: | Enzyme Subunit |
Mol. Mass.: | 10869.31 |
Organism: | Human immunodeficiency virus type 1 |
Description: | O38732 mutant |
Residue: | 99 |
Sequence: | PQITLWKRPIVTIRIGGQLKEALLDTGADDTVLEEMNLPGKWKPKMIGGIGGFIKVRQYD
QIPIEICGHKVISTVLVGPTPVNVIGRNLMTQIGCTLNF
|
|
|
BDBM13934 |
---|
Name | BDBM13934 |
Synonyms: | Atazanavir | BMS 232632 | CGP 73547 | CHEMBL1163 | Latazanavir | US10806794, Compound Atazanavir | methyl N-[(1S)-1-[[(2S,3S)-3-hydroxy-4-[[[(2S)-2-(methoxycarbonylamino)-3,3-dimethyl-butanoyl]amino]-[(4-pyridin-2-ylphenyl)methyl]amino]-1-phenyl-butan-2-yl]carbamoyl]-2,2-dimethyl-propyl]carbamate | methyl N-[(1S)-1-{[(2S,3S)-3-hydroxy-4-[(2S)-2-[(methoxycarbonyl)amino]-3,3-dimethyl-N'-{[4-(pyridin-2-yl)phenyl]methyl}butanehydrazido]-1-phenylbutan-2-yl]carbamoyl}-2,2-dimethylpropyl]carbamate |
Type | Small organic molecule |
Emp. Form. | C38H52N6O7 |
Mol. Mass. | 704.8555 |
SMILES | COC(=O)N[C@H](C(=O)N[C@@H](Cc1ccccc1)[C@@H](O)CN(Cc1ccc(cc1)-c1ccccn1)NC(=O)[C@@H](NC(=O)OC)C(C)(C)C)C(C)(C)C |r| |
Structure |  |
HIV-1 Protease Substrate |
---|
Name: | HIV-1 Protease Substrate |
Synonyms: | n/a |
Type: | Peptide |
Mol. Mass.: | 4728.18 |
Organism: | n/a |
Description: | n/a |
Residue: | 44 |
Sequence: | Arg-Glu(EDANS)-Ser-Gln-Asn-Tyr-Pro-Ile-Val-Gln-Lys(DABCYL)-
Arg
|
|
|